Solving Medical Mysteries in the World of Rar...

Cofounders Jeremy Wohlwend and Gabriele Corso join the a16z podcast to discuss the launch of Boltz, a public benefit company building AI infrastructure for molecular biology. The conversation explains how breakthroughs following AlphaFold moved the field beyond protein structure ...  Show more

In this episode, a16z GP Julie Yoo sits down with Peter McCanna, CEO of Baylor Scott & White Health, to break down how one of America's largest health systems is transforming from a supply-driven "walled castle" to a customer-centric ecosystem, and how it's achieving a 10% operat ...  Show more

Prions are biological anomalies – self-replicating, not-alive little particles that can misfold into an unstoppable juggernaut of fatal disease. Prions don't contain genes, and yet they make more of themselves. That has forced scientists to rethink the "central dogma" of molecula ...  Show more

Mapping the human genome led to big advances in diagnosing rare disease. But diagnosis is only the first step in dealing with an illness. So what do you do if your child is found to have a condition that has no treatment? We hear from Michelle Teng, a mother who co-founded a biot ...  Show more

There are neglected tropical diseases, and then there is Noma, a severe gangrenous disease which tends to affect 2 to 6-year-olds and has a 90% fatality rate. Its quick onset means that often children die before they can get medical attention and it is thought that many medical p ...  Show more

Like many autoimmune diseases, multiple sclerosis so clearly illustrates how detection and description of a disease only gets us so far when it comes to prevention, treatment, and cure. In the over 150 years since the first comprehensive description of multiple sclerosis, a great ...  Show more